Abbott Laboratories’ patent infringement suits against various companies relating to Tricor(R) remain pending.
Abbott is seeking to enforce its patent rights relating to fenofibrate tablets (a drug Abbott sells under the…
Abbot Laboratories’ patent infringement suits against various companies relating to Niaspan(R) are pending.
Abbott is seeking to enforce its patent rights relating to niacin extended release tablets — a drug Abbott…
Abbott Laboratories continues to dispute allegations in Medinol Limited’s remaining patent infringement suit in Europe.
In December 2008, Medinol sued Abbott in the High Court of Ireland, the District Court of…
The amount of disputed royalties and interest related to Medtronic, Inc.’s cardiac resynchronization therapy products was $111 million, as of October 29, 2010.
Medtronic is a licensee to the RE 38,119…
Medtronic Inc. and its subsidiary, Medtronic AVE, Inc., continue to be in dispute with Wyeth and Cordis Corporation over alleged infringement of “Morris” patents.
On February 22, 2008, Wyeth and Cordis…
The current balance in the interest-bearing escrow account for putative royalties for the 4,407,288 Patent to be paid by Medtronic, Inc. to Mirowski Family Ventures, LLC is $90 million as…
Edwards Lifesciences, Inc. has yet to seek leave for further appeals in Germany and the United Kingdom to a trial court ruling affirming that the Medtronic CoreValve LLC’s transcatheter aortic…
Pfizer Inc. is pursuing patent infringement actions against Apotex Inc., Apotex Corp. and Mylan Pharmaceuticals Inc.
In July 2010, the Company received notices from Apotex and from Mylan that they had…
Pfizer Inc. is pursuing a patent infringement action against Apotex, Mylan and Mylan Inc., Actavis Inc. and Actavis Pharma Manufacturing Pvt. Ltd., and Amneal Pharmaceuticals LLC.
In October 2010, the Company…
Pfizer Inc. is pursuing a patent infringement action against Lupin Limited.
In August 2010, Lupin notified the Company that it had filed an abbreviated new drug application with the FDA seeking…